2. Gene
  3. Erbb3 - erb-b2 receptor tyrosine kinase 3 Gene

Erbb3 - erb-b2 receptor tyrosine kinase 3 Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Rattus norvegicus

Also known as nuc-ErbB3

Gene ID: 29496 | Gene type: protein coding

About Erbb3

Primary_assembly 7: 996,225-1,015,525 reverse strand.mRatBN7.2:CM026980.1

This gene has 5 transcripts (splice variants), 280 orthologues, 54 paralogues and is associated with 44 phenotypes. Biased expression in Kidney (RPKM 239.), Liver (RPKM 25.8) and 7 other tissues.

Summary

Enables neuregulin binding activity and neuregulin receptor activity. Involved in several processes, including animal organ development; cellular response to Insulin stimulus; and positive regulation of glucose import. Located in nucleus and postsynaptic membrane. Biomarker of chronic obstructive pulmonary disease and median neuropathy. Human ortholog(s) of this gene implicated in lethal congenital contracture syndrome 2; lung adenocarcinoma; lung non-small cell carcinoma; and neuronal intestinal dysplasia type A. Orthologous to human ERBB3 (erb-b2 receptor tyrosine kinase 3). [provided by Alliance of Genome Resources, Apr 2022]

Erbb3 Products(1)

mRNA Protein Name
NM_017218.3 NP_058914.2 receptor tyrosine-protein kinase erbB-3 precursor

Erbb3 Protein Structure

Recep_L_domain

Recep_L_domain: pfam01030 (55 - 166)

Furin-like

Furin-like: pfam00757 (181 - 328)

Recep_L_domain

Recep_L_domain: pfam01030 (352 - 473)

GF_recep_IV

GF_recep_IV: pfam14843 (498 - 629)

TM_ErbB3

TM_ErbB3: cd12095 (637 - 673)

PKc_like

PKc_like: cl21453 (698 - 976)

  • 0
  • 300
  • 600
  • 900
  • 1200
  • 1339 a.a.
Protein Preferred Names Protein Names

receptor tyrosine-protein kinase erbB-3

avian erythroblastosis oncogene B 3

c-erbB-3

c-erbB3

proto-oncogene-like protein c-ErbB-3

v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3

v-erb-b2 erythroblastic leukemia viral oncogene homolog 3

Recombinant Erbb3 Proteins

Cat. No. Product Name Accession Purity
HY-P74892 HER3 Protein, Rat (HEK293, Fc) G3V6N1 (S20-H641) ≥95%

Related Agents

Clinical Phase
Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-13050 Sapitinib Inhibitor 99.93% Phase 2
Inhibitory Antibodies (6)
Cat. No. Product Name Effect
Purity Phase
HY-P99275 Patritumab Inhibitor 98.95% Phase 3
HY-P99268 Seribantumab ≥95.0% Phase 2
HY-P99866 Duligotuzumab 97.93% Phase 2
HY-P99672 Istiratumab Inhibitor / Phase 2
HY-P99304 Lumretuzumab Inhibitor 95.00% Phase 1
HY-P99461 Barecetamab Inhibitor 97.96% Phase 1
Pre-clinical Phase
Bioactive Molecules (9)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-100848 TX1-85-1 Inhibitor 98.04% Unkown
HY-18609 PD158780 Inhibitor 99.56% Unkown
HY-W006886 Fmoc-(R)-2-(7-octenyl)Ala-OH 98.85% Unkown
HY-118998 TX2-121-1 Inhibitor / Unkown
HY-13050A Sapitinib fumarate Inhibitor / Unkown
HY-RS04469 ERBB3 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS04470 Erbb3 Mouse Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS04471 Erbb3 Rat Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-164548 WK88-1 / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Erbb3 NCBI NCBI:2065
Mus musculus Erbb3 NCBI NCBI:13867
Macaca mulatta Erbb3 NCBI NCBI:711407